Skip to main content
Bulletin of the National Research Centre

Table 7 Structure, predicted pIC50 and MolDock scores of the designed compounds

From: In-silico activity prediction, structure-based drug design, molecular docking and pharmacokinetic studies of selected quinazoline derivatives for their antiproliferative activity against triple negative breast cancer (MDA-MB231) cell line

Back to article page